Ann: Megachips License Agreement, page-363

First 363 Last

Share
Profile

Follow
Easytiger

280 Posts.

12

22/11/21

19:13

Post #: 57763096
Share

Originally posted by Fact Finder: ↑

I have explained this at length a long time ago but it is as simple as I do not want to take on the responsibility for other people's investment decisions. I am not a financial advisor and I have seen first hand that even when you know the person you tell about a share and you suggest the limits they might place on their investment it does not end there as they will invariably invest more and tell others and reference you as the source of the advice to buy.

I try to make it absolutely clear that I am biased because I own shares in Brainchip and I want to make a profit. I encourage people not to believe a word I say and to do their own research every single time.

If you check my posting history over the last several years I have not posted on any other share as I was shocked when a number of posters and long term shareholders said that at times the only reason they had remained invested in Brainchip was because of my posts. It occurred to me that if I posted on another share this might lead some to invest in that company as well. I have even been asked what other shares I invest in.

I am also ashamed of the fact that on the Brainchip threads there are clearly a group of very dishonest traders (I could use other words) who make a profession of spreading misinformation and fear so they can profit off the fear of others which can be countered by a solid understanding of the company and I have a memory for narrative and mostly to respond with the facts requires little time or thought.

So in a nut shell never is the answer to your question.

My opinion only DYOR
FF

AKIDA BALLISTA

Expand

fair play FF

BRN Price at posting: 65.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

There are more pages in this discussion • 129 more messages in this thread...

First 363 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change 0.020(8.51%)		Mkt cap ! $500.4M

Open	High	Low	Value	Volume
22.5¢	27.5¢	22.0¢	$8.399M	33.52M

Buyers (Bids)

No.	Vol.	Price($)
6	338805	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	10000	1

View Market Depth

No.	Vol.	Price($)
6	338805	0.255
15	429045	0.250
13	731308	0.245
9	88244	0.240
6	93087	0.235

Price($)	Vol.	No.
0.260	10000	1
0.265	231580	5
0.270	636408	10
0.275	501185	11
0.280	1156121	31

Last trade - 16.10pm 02/10/2024 (20 minute delay)

BRN (ASX) Chart

Ann: Megachips License Agreement, page-363

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Megachips License Agreement, page-363

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News